|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
43,580,000 |
Market
Cap: |
2.75(M) |
Last
Volume: |
4,407,900 |
Avg
Vol: |
2,197,486 |
52
Week Range: |
$0.0632 - $0.0632 |
|
Level
I Sector: |
Financials |
Level
II Sector: |
Financial Services |
Level
III Sector: |
Diversified Investments |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile China Pharma Holdings is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with a variety of diseases and medical conditions. Co. manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Co. manufactures pharmaceutical products for a variety of diseases and medical indications, each of which may be classified into the following categories: basic generic drugs; first-to-market generic drugs; and Chinese medicines. In addition, Co. manufactured healthcare products and protective products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Liu Tao (chengdu) |
10% Owner |
|
2023-12-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,000,000 |
|
- |
|
Li Zhilin |
CEO & Interim CFO |
|
2023-09-29 |
4 |
A |
$0.14 |
$1,925,989 |
D/D |
13,757,063 |
15,138,063 |
|
- |
|
Deng Ke |
10% Owner |
|
2022-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,552,230 |
|
-34% |
|
Li Zhilin |
CEO & Interim CFO |
|
2021-09-09 |
4 |
A |
$0.67 |
$1,179,200 |
D/D |
1,760,000 |
13,810,000 |
|
- |
|
Li Zhilin |
CEO and interim CFO |
|
2020-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000,000 |
12,050,000 |
|
- |
|
5 Records found
|
1
|
Page 1 of 1 |
|
|